In addition, 69.1% achieved at least 10% weight loss, and 50.5% achieved at least 15% weight loss
HHS later referred the company to the Department of Justice after it announced the launch of a $49 version of Novo Nordisks Wegovy pill
Researchers at Johns Hopkins University are expected to commence a multi-site, double-blind, randomized, placebo-controlled study examining the effect of GLP-1s on brain volume via MRI as well as other blood-based biomarkers
Outcome misclassification : patients may label vulvar skin laxity, pelvic floor weakness, bleeding changes, and libido/arousal effects under the umbrella of vaginal changes, requiring clearer phenotyping
Some individuals prefer morning administration as it fits naturally into their daily routine alongside other morning activities
Wilding JP et al